Dopamine regulates spine density in striatal projection neurons in a concentration-dependent manner. by Alberquilla, S. et al.
Contents lists available at ScienceDirect
Neurobiology of Disease
journal homepage: www.elsevier.com/locate/ynbdi
Dopamine regulates spine density in striatal projection neurons in a
concentration-dependent manner
Samuel Alberquillaa, Aldo Gonzalez-Granilloa,c,d, Eduardo Daniel Martína,1,
Rosario Moratallaa,b,⁎,1
a Instituto Cajal, Consejo Superior de Investigaciones Científicas (CSIC), 28002 Madrid, Spain
b Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, 28031 Madrid, Spain
c Laboratorio de neuropsiquiatría, Instituto de Fisiología, Benemérita Universidad Autónoma de Puebla, México
d Laboratorio de Fisiología de la Conducta, Escuela Nacional de Ciencias Biológicas, Instituto Politécnico Nacional, Mexico









A B S T R A C T
Dopaminergic afferents innervate spiny projection neurons (SPNs) in the striatum, maintaining basal ganglia
activity. The loss of striatal innervation is the hallmark of Parkinson's disease (PD), which is characterized by
dopaminergic denervation. A lack of dopamine in the dorsal striatum induces plasticity changes in SPNs.
However, PD-associated denervation is progressive, and how plasticity is modified in partially innervated areas
is poorly understood. The most studied models of PD are based on the use of neurotoxins that induce an almost
complete striatal denervation. To investigate the impact of partial dopamine (DA) innervation in striatal plas-
ticity, we use a genetic model of PD, Aphakia (Ak) mice, whose striatum presents an increasing dorso-ventral
gradient of dopamine innervation. We studied SPNs in three different areas (dorsal, middle and ventral, with
low, moderate and high innervation by tyrosine hydroxylase TH-positive axons, respectively) using fast scan
cyclic voltammetry, microiontophoresis, immunohistochemistry and patch clamp techniques. Our data show an
increasing dorso-ventral gradient of extracellular DA levels, overlapping with the gradient of TH innervation.
Interestingly, spine loss in both direct (d-SPN) and indirect SPNs (i-SPN) decreases from dorsal to ventral in the
parkinsonian striatum of Ak mice, following the decrease in DA levels. However, their dendritic trees and the
number of nodes are only reduced in the poorly innervated dorsal areas and remain unaltered in moderate and
highly innervated areas. The firing rate of direct SPNs does not change in either moderate or highly innervated
areas, but increases in poorly innervated areas. In contrast, action potential frequency of indirect SPNs does not
change along the dorso-ventral innervation gradient. Our findings indicate that spine density in d-SPNs and i-
SPNs varies in a dopamine concentration-dependent manner, indicating that both d- and i-SPN are similarly
innervated by DA.
1. Introduction
The striatum is essential for action selection, modulating the control
and integration of movement and non-motor functions, such as cogni-
tive processes and limbic functions. The striatum is the major input
nucleus of the basal ganglia. It receives dopaminergic innervation from
the substantia nigra pars compacta (SNc) and ventral tegmental area
(VTA) and glutamatergic innervation from the cortex and thalamus.
The striatum is mainly formed by spiny projection neurons (SPNs),
which are categorized into two types. The neurons that express dopa-
mine D1 receptors (D1R) form the direct pathway (d-SPN) and facilitate
motor behavior. Those that express D2 receptors (D2R) form the
indirect pathway (i-SPN) and inhibit movements (Albin et al., 1989;
Kravitz et al., 2010). Both types of neurons are GABAergic and exhibit
low firing rates and low excitability because of their high threshold for
action potentials.
The loss of striatal innervation or the axospinous synapses that carry
motor information from dopaminergic neurons is the hallmark of
Parkinson's disease (PD). Loss causes major synaptic dysfunction, with
marked dendritic tree atrophy and a severe decrease in spine density in
both d- and i-SPNs in the striatum (Day et al., 2006; Solís et al., 2007;
Villalba et al., 2009; Fieblinger et al., 2014; Nishijima et al., 2014;
Suarez et al., 2014, 2016, 2018; Toy et al., 2014; Gagnon et al., 2017;
Lieberman et al., 2018; Graves et al., 2019). However, it remains
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unknown whether the moderate DA levels in partially denervated/in-
nervated striatal areas are able to trigger these changes and modify the
synaptic morphology and intrinsic properties of SPNs.
We hypothesized that nigrostriatal dopaminergic innervation is di-
rectly associated with changes in the morphology and physiology of
SPNs according to the extracellular levels of DA. To test this, we took
advantage of Pitx3−/− aphakia (Ak) mice that, due to the selective lack
of SNc DA neurons in the midbrain, present an increasing dorso-ventral
gradient of dopaminergic innervation (Smidt et al., 2004). Pitx3 is a
transcription factor expressed by midbrain DA neurons and is important
for their terminal differentiation and survival. In Ak mice, the few
Pitx3-independent DA neurons able to survive provide a gradient of
striatal DA innervation increasing from dorsal to ventral, a state that is
associated with motor impairments and other related signs of Parkin-
son's disease (Solís et al., 2015; García-Montes et al., 2018). This mouse
line has been established as a model of moderate PD (Solís et al., 2015).
Notably, the synaptic alterations and plasticity changes in patients
(McNeill et al., 1988; Zaja-Milatovic et al., 2005) and in completely
denervated striatal areas in PD mouse models (Graves et al., 2019) are
also reproduced in Ak mice (Solís et al., 2015; Suarez et al., 2018;
Lieberman et al., 2018).
2. Methods
2.1. Animals
This study was carried out in 1- to 3-month-old male hemizygous
BAC-transgenic mice (D1R-tomato and D2R-eGFP, C57BL/6) crossed
with WT or with homozygous Pitx3−/− (C57BL/6) or Ak mice. Red
tomato and green GFP fluorescence were used to identify d-SPNs and i-
SPNs, respectively. Animals were group-housed and kept on a 12 h
light/dark cycle with ad libitum access to food and water. All proce-
dures were performed in accordance with the guidelines from European
Union Council Directive (86/609/European Economic Community).
3. Brain slice preparation
Mice were anesthetized and transcardially perfused with artificial
cerebrospinal fluid (aCSF) that contained: 124mM NaCl, 2.69mM KCl,
1.25mM KH2PO4, 2mM MgSO4, 26mM NaHCO3, 10mM D-glucose,
and 2mM CaCl2 at pH 7.4. Coronal brain slices (400 μm thick) of
neostriatum were prepared using conventional methods (Oliva et al.,
2013), and incubated in a holding chamber at room temperature
(21–24 °C) in aCSF and gassed with carbogen (95% O2 and 5% CO2).
3.1. Fast-scan cyclic voltammetry
Fast-scan cyclic voltammetry (FSCV) recordings were performed in
three different areas of striatal slices following the dorso-ventral axes
corresponding to the dorsal striatum (s1-s3), middle striatum (s4-s6)
and the ventral striatum (s7-s9). FSCV at the carbon fiber electrode
(CFE; 10 μm diameter; 50 μm exposed length) was used to detect
changes in extracellular concentrations of DA following a puff of KCl
(400mM). FSCV was carried out using three electrode voltage-clamp
amplifiers (VAMP-1, Registim LLC, Coral Gables, FL, USA) as previously
described (Granado et al., 2011; Ares-Santos et al., 2012; Oliva et al.,
2013). CFE was used as the working electrode, Ag/AgCl pellet as the
reference electrode and a platinum wire as the auxiliary electrode. A
voltage scan rate of 400 V/s was applied consecutively every 200ms to
the CFE. Changes in extracellular DA were determined by monitoring
the current at the peak oxidation potential for DA. Background-sub-
tracted cyclic voltammograms were created by subtracting the current
before stimulation from the current in the presence of DA (Fig. 1C).
Current was digitized at 10 kHz using a PowerLab 4/25 T (AD Instru-
ments, Bella Vista, Australia) acquisition system. Data were acquired
and analyzed with Scope software (AD Instruments). Electrodes were
calibrated with DA standards of known concentration (0.5, 1, 2, 3 and
5 μM DA) in the recording chamber. The average of set of measure-
ments was used as the calibration factor.
3.2. Electrophysiology
Whole-cell electrophysiological recordings were performed as pre-
viously described (Martin et al., 2012) in three different areas of striatal
slices following the dorso-ventral axes corresponding to the dorsal
striatum (s1-s3), middle striatum (s4-s6) and the ventral striatum (s7-
s9). Patch pipettes were pulled from thick-walled borosilicate glass with
a model P-97 micropipette puller (Sutter Instruments, Novato, CA).
Pipettes (3–5MΩ) were filled with the internal solution that contained:
100mMK-Gluconate, 32.5 mM KCl, 10mM HEPES, 5mM EGTA, 1mM
MgCl2, 4 mM ATP-Na2 and 0.4mM GTP-Na2 (pH adjusted to 7.3 with
KOH). Slices were transferred to an immersion recording chamber and
continuously perfused with aCSF solution gassed with carbogen (95%
O2 and 5% CO2). d-SPNs (red) and i-SPNs (green) were identified under
fluorescence illumination. Electrophysiological recordings were ob-
tained using a Multiclamp 700B amplifier and analyzed using a digital
system (pClamp version 11.0, Molecular Devices). Excitability was
obtained using 500ms somatic current injection in current clamp mode.
3.3. Single-cell microinjection and immunohistochemistry
Animals were anesthetized with sodium pentobarbital (50mg/kg,
i.p.) and transcardially perfused with 4% paraformaldehyde (pH 7.4).
Brains were post-fixed for 24 h in the same solution. Coronal sections
were obtained on a vibratome (Leica, RRID: SCR_008960). The cutting
sequence was 200 and 30 μm thick sections throughout the entire
striatum, following the protocol previously described by Suarez et al.
(2014; Supplementary Fig 1). 200 μm sections were used for Lucifer
Yellow injections and morphological reconstruction of SPNs. d-SPNs
(red fluorescence) and i-SPNs (green fluorescence) were impaled with a
micropipette containing 8% Lucifer Yellow (Sigma-Aldrich), injected
with 10–20 nA of hyperpolarizing current, and slices were processed for
immunocytochemistry with the anti-Lucifer Yellow antibody
(1:100,000; kindly provided by Dr. De Felipe, CSIC) as described pre-
viously (Suarez et al., 2014, 2016, 2018). Neurolucida v8 (Micro-
BrightField RRID: SCR_001775) was used to trace 3-dimensional den-
dritic arbors of SPNs and to mark spines. To determine in which striatal
region each neuron was positioned, 30 μm sections were used for TH
(1:1000; Millipore AB1542, RRID: AB_11213126). Immunofluorescence
micrographs were obtained using confocal microscopy (Leica) at 63× .
3.4. Quantitative assessment of dopaminergic fibers in the striatum
For the analysis of dopaminergic fibers in the striatum, we used an
image analysis program (ImageJ) to convert color intensities into a gray
scale. Striatal sections were taken with an optical microscope with a 4×
lens. To choose the threshold that would be applied to all the groups,
we use an average of WT slices in which the amount of TH fibers was
maximum (around 100%) and was applied to Ak animals to determine
the % TH fibers. We measured the area of staining in the striatum as the
proportion of pixels in the striatum that show staining relative to the
total pixels in the striatum (Ares-Santos et al., 2014).
3.5. Statistics
FSCV, % TH fibers, total dendritic length and distal spines were
analyzed using one-way ANOVA followed by the Bonferroni post-hoc
test. Electrophysiological and Sholl analyses were conducted using two-
way ANOVA followed by the Bonferroni post-hoc test. Analysis was
performed with GraphPad Prism 5 (La Jolla). Data are expressed as the
mean ± standard error of the mean (SEM).
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4. Results
4.1. Aphakia mice show a dorso-ventral gradient of extracellular DA levels
correlating with TH innervation
Ak mice show a dorso-ventral gradient of dopamine innervation in
the striatum (Smidt et al., 2004; Solís et al., 2015; Suarez et al., 2018)
with ventral areas more innervated than dorsal areas, where only a few
TH fibers remain (Fig. 1A, B). In order to test whether the extracellular
DA levels matches the dorso-ventral gradient of dopaminergic
innervation, we quantified TH fibers along the dorso-ventral striatal
axis by optical density. This quantification allowed us to divide the
striatum into three different areas: dorsal with just 16.41% ± 3.31 TH
fibers; middle with 64.91% ± 3.12 and ventral with 93.41% ± 1.60
(Fig. 1B, B'). Such a TH gradient was not observed in the WT, in which
the values ranged from 90.79% ± 1.86 for dorsal, 89.6% ± 5.67 for
middle and 90.59% ± 1.24 for ventral striatum (Fig. 1B").
To know if the extracellular DA levels in Ak mice correlated with the
dorsoventral gradient of dopaminergic innervation, we recorded from
these three selected areas, at three different sites (s1, s2, s3, etc) per
Fig. 1. Ak mice show an increasing striatal dorso-ventral gradient of extracellular DA levels correlating with TH innervation. Striatal coronal sections of WT and
Aphakia mice stained with TH illustrating the striatal gradient of dopamine innervation in Ak mice (A) and the location of the carbon fiber and KCl pipette for
recording sites in the dorsal, middle and ventral striatal areas, corresponding to low, moderate and high TH-innervation, respectively (B). (C) Top, the applied voltage
to the carbon fiber consists of a triangular waveform with a voltage scan rate of 400 V/s. Middle, the current evoked by the input voltage at the carbon fiber. When
DA is in the extracellular medium, there is an increase in the current due to its oxidation (o) and reduction (r). Bottom, background-subtracted voltammograms and
representative peak of DA in the three different striatal areas of Ak and WT mice. (B′, B″) Histograms represent mean percentage of TH innervation measured as
optical density in the three striatal areas in Ak mice, n=15 slices, (B′) and WT mice, n=9 slices, B". (C′, C″) Mean peak dopamine concentrations in the dorsal
(n=35 slices, s1-s3), middle (n=38 slices, s4-s6) and ventral (n=9 slices, s7-s9) areas of Ak and correlation analysis showing the relationship between TH
innervation and DA overflow (C′). Mean peak of dopamine concentrations in WT mice (C″) (n=34 slices).
Significant differences were established by one-way ANOVA followed by Bonferroni's test at ****p < .0001 vs. WT; #p < .05, ####p < .0001 vs. Ak Dorsal;
$$$p < .001, $$$$p < .0001 vs. Ak Middle. Scale bar: 500 μm, A; 300 nA and 400ms, C top; 0.5 μM DA and 500ms, C bottom.
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area, using FSCV to measure dopamine overflow (Fig. 1B, C). This
method allows us to detect electrochemically active neurotransmitters
based on their oxidation and reduction properties (Armstrong-James
and Millar, 1979). In parallel with the TH fiber innervation, we found
that the dorsal striatum of Ak mice present low extracellular DA levels
(1.2 μM ± 0.06), followed by the middle and ventral areas
(1.61 μM ± 0.1 and 2.19 μM ± 0.16, respectively; Fig. 1C'), while
extracellular DA levels in WT mice does not change along the dorso-
ventral axis (dorsal 2.47 μM ± 0.15, middle 2.64 μM±0.16 and ven-
tral 2.58 μM±0.18; Fig. 1C"). Additionally, correlation analysis shows
the relationship between TH innervation and extracellular DA levels.
Our results show that there is a gradient of extracellular DA levels along
the dorso-ventral striatal axis in Ak mice, which follows the dorso-
ventral gradient of TH fibers.
4.2. SPN morphology is modified along the dorso-ventral striatal axis of
Aphakia mice according to DA concentration
The morphological plasticity of projection neurons in completely
denervated dorsal striatal areas has been intensively studied using
different mouse models of PD (Fieblinger et al., 2014; Suarez et al.,
2014, 2016, 2018; Graves and Surmeier, 2019). Yet, although PD is
progressive, the structural synaptic changes of SPNs in partially de-
nervated striatal areas and how these changes occur has never been
addressed. Here, in order to see how different DA levels affect synaptic
plasticity, we studied whether spine density and dendritic morphology
of SPNs follow the dorso-ventral gradient of extracellular DA levels and
TH fiber innervation in the striatum of Ak mice (Fig. 2). We analyzed
the morphology of SPNs with Lucifer yellow (LY) microiontophoresis in
the three differently innervated striatal areas in 200 μm thick slices
(Fig. 2A). To distinguish between the three areas in the 200 μm slices,
we used adjacent slices (30 μm thick) stained with TH as depicted in
Fig. 2B, C.
We found that dendritic arborization was not significantly modified
in the middle (2749 μm ± 255.6 for d-SPNs, 2074 μm ± 181.3 for i-
SPNs) or ventral striatum (2870 μm ± 341 for d-SPNs,
1944 μm ± 270.7 for i-SPNs). However, the dendritic arborization of
both d-SPNs (1599 μm ± 157.5) and i-SPNs (962.7 μm ± 72.49) in
the dorsal striatum of Ak mice was decreased compared to WT (mea-
sured as the mean of the three striatal regions; 2320 μm ± 104.4,
1789 μm ± 204.3; Fig. 3 A, B). In addition, only in the poorly in-
nervated areas was there a reduction in the number of nodes in both d-
SPN and i-SPN (d-SPN: 18.07 ± 1.26, WT; 13.32 ± 0.92, Ak dorsal;
18.42 ± 1.39, Ak middle and 20.42 ± 2.02, Ak ventral; i-SPN:
16.07 ± 2.04, WT; 9.68 ± 0.77, Ak dorsal; 17.33 ± 1.25, Ak middle
and 16.42 ± 1.25, Ak ventral; Fig. 3C). However, we did not find
significant differences in the number of primary dendrites in SPNs
(Fig. 3D) along the dorso-ventral innervation gradient. Because there is
no differential gradient of DA or TH across the striatum in WT mice we
tested that DA does not regulates the total length SPN (d-SPN:
2428 μm ± 191.3, WT dorsal; 2220 μm ± 180, WT middle and
2325 μm ± 189.1, WT ventral; i-SPN: 1823 μm ± 253.9, WT dorsal;
1963 μm ± 311.7, WT middle and 1585 μm ± 472.9, WT ventral)
nodes (d-SPN: 16.75 ± 1.84, WT dorsal; 18.6 ± 2.64, WT middle and
18.67 ± 1.97, WT ventral; i-SPN: 19.4 ± 4.65, WT dorsal;
15 ± 3.05, WT middle and 13.8 ± 5.64, WT ventral) or primary
dendrites (d-SPN: 7.43 ± 0.87, WT dorsal; 7.75 ± 0.45, WT middle
and 8 ± 0.52, WT ventral; i-SPN: 6.8 ± 0.49, WT dorsal; 7 ± 0.89,
WT middle and 9.2 ± 1.24, WT ventral) in both SPNs in a con-
centration-dependent manner (Figure supplementary 1).
This suggests that even moderate DA levels are sufficient to main-
tain the dendritic tree and nodes in the striatal neurons.
Next, we measured the spine density in the proximal (< 45 μm) and
distal parts of the dendrites (from 45 μm onwards). We did not find
differences in the proximal spine density in both SPNs of WT mice along
the dorso-ventral axis (dSPN: 2.68 ± 0.61, WT dorsal; 2.95 ± 0.56,
WT middle and 2.34 ± 0.62, WT ventral; iSPN:: 2.23 ± 0.51, WT
dorsal; 3.09 ± 0.53, WT middle and 2.95 ± 0.76, WT ventral); Figure
supplementary 2. Curiously, we found a reduction in the proximal spine
density in both d-SPNs and i-SPNs in Ak mice (d-SPN: 1.44 ± 0.19 for
dorsal; 1.07 ± 0.17, middle and 1.34 ± 0.15 in the ventral striatum
compared to 2.37 ± 0.30 in the WT mice; i-SPN: 1.43 ± 0.27 for
dorsal; 1.28 ± 0.31, middle and 1.57 ± 0.19 ventral compared to
2.78 ± 0.34 in the WT mice, measured as the mean of the three striatal
regions; Fig. 4C). Specifically, the decrease in proximal spine density
remains constant across the striatal gradients in Ak mice. In relation to
distal spine density, we did not find differences in both SPNs of WT
mice along the dorso-ventral axis (dSPN: 7.72 ± 0.58, WT dorsal;
8.13 ± 0.67, WT middle and 8.44 ± 0.79, WT ventral; iSPN:
7.25 ± 0.45, WT dorsal; 7.52 ± 1.17, WT middle and 8.44 ± 1.11,
WT ventral). In addition, we also observed a gradient of distal spine
density as a function of DA concentration (Fig. 4D). We first re-
confirmed spine loss in the dorsal striatum of Ak mice, the area with the
lowest extracellular DA levels (3.71 ± 0.33 for d-SPNs; 3.69 ± 0.28
for i-SPNs). In the partially innervated areas (middle striatum), where
TH innervation is greater than in the dorsal part, spine density is in-
termediate (5.5 ± 0.45 in d-SPNs; 5.66 ± 0.52 in i-SPNs). The spine
density in this middle striatal area of Ak mice is statistically different
from the dorsal and ventral parts of the striatum. In the ventral striatum
of Ak mice, as expected, there were no changes in spine density
(6.73 ± 0.46 in d-SPNs; 6.64 ± 0.55 in i-SPNs) compared to WT an-
imals (8.06 ± 0.37 in d-SPNs; 7.68 ± 0.5 in i-SPNs), since TH fibers
and extracellular DA levels are similar to those in WT mice.
4.3. Striatal excitability is altered in d-SPNs
First, we did not find differences in the firing rate of both SPNs
along the dorso- ventral axis in WT mice (Fig. 5A). To determine if these
morphological changes correlate with striatal excitability, we studied
the firing rate in Ak mice. In the middle and ventral striatum, the ex-
citability of d-SPNs remained unchanged (Fig. 5B) while the firing rate
of d-SPNs was increased in the dorsal striatum. However, there were no
changes in the excitability of i-SPNs along the dorso-ventral axis
(Fig. 5B). This finding indicates that significant (> 80%) loss of striatal
DA terminals like that found in dorsal striatum appears necessary to
induce a hyperexcitability state of d-SPNs, while i-SPNs remain less
affected.
5. Discussion
The motor symptoms of PD are closely coupled with the gradual
degeneration of SNc dopaminergic neurons, which induces progressive
denervation of SPNs. This leads to hypoactivity of d-SPNs and hyper-
activity of i-SPNs, generating a reduction in movement. The most
common PD models were based on the use of neurotoxins including 6-
hydroxydopamine (6-OHDA; Day et al., 2006; Zhang et al., 2013;
Fieblinger et al., 2014, 2018; Suarez et al., 2014, 2016; Gagnon et al.,
2017; Ketzef et al., 2017) and 1-methyl-4-phenyl-1,2,3,6-tetra-
hydropyridine (MPTP; Villalba et al., 2009; Toy et al., 2014). These
models induce severe, almost complete striatal denervation. In contrast,
clinical observations in patients suggest that motor symptoms appear
when the afferent deficit is> 50% (Kordower et al., 2013). During the
preclinical stage, there is a time window in which the progressive loss
of the dopaminergic neurons is asymptomatic, reflecting the capacity of
the system to compensate for the gradual loss of DA. It is possible that
moderate levels of DA in the striatum are able to maintain the SPNs
homeostatic activity and therefore delaying the appearance of motor
symptoms. For this reason, the study of the morphology and functional
activity in the partially innervated striatal area is essential to under-
stand the progression of PD symptoms. The SPNs located in the partially
innervated striatum are playing a critical role in the maintenance of
global striatal function while dopaminergic neurons in the SNc are
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degenerating.
One of the best PD mice models to study synaptic morphology in
partially innervated striatal areas is the Ak mouse, which recapitulates
moderate stages of the disease in PD patients. Ak mice are deficient in
the transcription factor Pitx3, affecting primarily dopaminergic neurons
in the SNc, where there are only a few neurons present (Kouwenhoven
et al., 2017; Smidt et al., 2004), providing partial striatal innervation.
Consequently, Ak mice show impaired spontaneous locomotor activity
and motor coordination (Nunes et al., 2003; Solís et al., 2015; Suarez
et al., 2018, García-Montes et al., 2019). Partial TH innervation in Ak
mice is distributed in a dorso-ventral gradient and provides an ideal
tool to study structural and functional plasticity under conditions of
different degrees of dopamine innervation. The aim of this study was to
elucidate how different degrees of dopaminergic inputs modify the
dendritic morphology and excitability of d-SPNs and i-SPNs. We found
that Ak mice, with their dorso-ventral gradient of TH innervation, also
show a dorso-ventral gradient of extracellular DA levels. Ak mice have
low extracellular DA levels in the dorsal striatum, where there is low TH
innervation, moderate or intermediate extracellular DA levels in the
middle, where TH innervation ranges from 50 to 70%, and extracellular
Fig. 2. 3D reconstruction of SPN and experimental design. (A) Complete morphological reconstruction of SPNs (green) in the dorsal, middle and ventral striatal areas
showing low, moderate and high TH fiber innervation (red). (B) Rostro-caudal pairs of LY-intracellularly injected SPN sections with its corresponding adjacent TH-
stained sections. (C) Diagram illustrating the pairing of 200 μm thick sections for LY injections with their adjacent 30 μm thick section stained with TH throughout the
striatal rostro-caudal axis. Scale bar: 50 μm, A; 500 μm, B. (For interpretation of the references to color in this figure legend, the reader is referred to the web version
of this article.)
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DA levels similar to WT in the ventral areas, where innervation is
comparable to WT animals. According to these gradients, changes in
structural plasticity in both d-SPNs and i-SPNs are directly correlated
with extracellular DA levels. However, in agreement with previous re-
sults (Lieberman et al., 2018), only the d-SPNs in the dorsal striatum
(with a severe lack of DA) increase their excitability.
The number of nodes and the size of the arbor tree in d-SPNs and i-
SPNs are maintained through intermediate and normal levels of DA (in
the middle and ventral striatum, respectively). One possibility is that
dendritic atrophy occurs by an “all or none” phenomenon. These results
are in agreement with the findings of Tiroshi and Goldberg (2019) that
indicate that the dendritic tree has a critical role in maintaining the
basal ganglia system.
The different morphology changes in both types of striatal projec-
tion neurons are still hotly debated. We show that the two striatal
neurons respond similarly to DA changes probably because both receive
similar dopaminergic innervation from the SN. Interestingly, we ob-
served a drastic reduction of proximal spines (< 45 μm) in SPNs along
the dorso-ventral axis, independent of the dopamine gradient. Thus, it
is difficult to understand why in proximal dendrites, spine density is
Fig. 3. Morphological changes of d-SPNs and i-SPNs along the striatal dorso-ventral gradient of TH innervation. (A) Representative drawings of the Sholl length. (B)
Sholl analysis of length of d-SPNs (top left) and total length (top right) in WT (n=23 neurons) and in Ak mice, dorsal (n=24), middle (n= 23) and ventral (n=9).
Sholl analysis of length of i-SPNs (bottom left) and total length (bottom right) of i-SPNs in WT (n=17 neurons) and in Ak mice, dorsal (n=19 neurons), middle
(n=20) and ventral (n=10 neurons). (C) Number of nodes of d-SPNs (top) and i-SPNs (bottom). (D) Number of primary dendrites of d-SPNs (top) and i-SPNs
(bottom).
Significant differences were established by one-way ANOVA followed by Bonferroni's test at *p < .05, **p < .01 vs. WT; # p < .05, ## p < .01, ### p < .001 vs.
Ak Dorsal.
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similarly reduced in dorsal, middle and ventral striatum. One possibility
is that there may be sparse dopaminergic innervation in the proximal
dendrites (< 45 μm) and spine density in this region could be modu-
lated by other factors. Findings from Villalba et al. (2013) show a sig-
nificant decrease in the total number of glutamatergic terminals in the
putamen of MPTP-treated parkinsonian monkeys. SPNs undergo com-
plex pathologic modifications of glutamatergic synapses in response to
dopaminergic denervation. Another possibility is the interaction be-
tween the astrocytes and SPNs. On the one hand, Martín et al. (2015)
demonstrate the existence of functional astro-neuronal networks that
comprise two distinct subpopulations of astrocytes in the striatum that
communicate selectively with distinct populations of SPNs. However,
the role of this bi-directional communication between astrocytes and
neurons in PD is unknown. Moreover, there is an increase in the extent
of glial coverage of striatal glutamatergic synapses in parkinsonian
monkeys and the astroglial processes are much tighter and continuous
than in WT animals (Villalba and Smith, 2011).
A body of evidence supports the pivotal role of dopamine in spine
growth. For instance, Ingham and colleagues first demonstrated a
drastic decrease of spine density in the dopamine-depleted striatum in
the 6-OHDA model (Ingham et al., 1989), an effect also observed in PD
patients (Zaja-Milatovic et al., 2005). Conversely, Robinson and Kolb
(1997) observed that amphetamine administration, which increases
dopamine in the synapse, produced an increase in the number of spines
in SPNs. Supporting these studies, restoring dopamine levels in PD with
its precursor L-3,4-dihydroxyphenylalanine (L-DOPA) induces spine
growth in i-SPNs (Scholz et al., 2008; Fieblinger et al., 2014; Suarez
et al., 2014, 2016, 2018). Experiments with cultured SPNs have shown
that DA increases the number of spines (Fasano et al., 2013) and finally,
Yagishita et al. (2014) reported that spine enlargement is mediated by
DA. These authors found a temporal window of DA actions on the
structural plasticity of dendritic spines. Together, our results support a
direct link between DA and structural plasticity in the striatum in a DA
concentration-dependent manner.
The impact of dopamine loss on SPN excitability is still a matter of
controversy. Several authors have shown hyperexcitability of d-SPNs in
different PD animal models (Fieblinger et al., 2014, 2018; Lieberman
et al., 2018; Maurice et al., 2015; Suarez et al., 2014; Suarez et al.
2018). However, the same authors have found different results re-
garding the spike rate of i-SPNs. Lieberman et al. (2018) and Maurice
et al. (2015) did not find changes in i-SPN excitability in PD mouse
models compared with WT mice. Suarez et al. (2014, 2018) showed an
increase of burst firing of i-SPNs, however, Fieblinger et al. (2014)
found i-SPNs had lower spike rates than those in WT mice.
Here, we found an increase in the intrinsic excitability of d-SPNs in
the dorsal striatum while, in the middle and ventral striatum, the ex-
citability of d-SPNs was unchanged. Singh et al. (2016) demonstrated
increased burst firing of SPNs in PD patients, but in their study, the two
populations of striatal neurons could not be distinguished. However, in
PD animal models, in agreement with our results, the lack of DA in the
dorsal striatum induces hyperexcitability in d-SPNs (Fieblinger et al.,
2014, 2018; Suarez et al., 2018). Indeed, the lack of D1R stimulation
facilitates corticostriatal synapses and an increasing firing rate. The
imbalance between d-SPN and i-SPN excitability could be due to tha-
lamostriatal transmission, because post-mortem studies in PD patients
(Henderson et al., 2000) and MPTP models (Villalba et al., 2014) have
shown neuronal death in the intralaminar thalamic nuclei. Another
explanation could be increased serotonergic striatal innervation, be-
cause there is gradual serotonin hyperinnervation inversely related to
the dorso-ventral DA gradient (Li et al., 2013).
In i-SPNs, the regulation of firing rate could be tuned by homeo-
static mechanisms to maintain global striatal activity. The excitability
of i-SPNs is not increased in the totally denervated area, in agreement
with Lieberman et al. (2018) that used young mice (p28). We recently
demonstrated that i-SPNs show an increased firing rate in the dorsal
striatum of Ak mice (Suarez et al., 2018). In that study, experiments
were performed in three to four-month-old mice. Here, we performed
electrophysiological recordings in one to three-month-old mice. Ac-
cording to our results from a previous study (Suarez et al., 2018) where
we used 3–4months old Ak mice, in contrast to the 1–3month old Ak
mice used here, it is possible that prolonged reductions in striatal DA
lead to SPN spine loss and subsequently an increase in the neural ex-
citability. The age-dependent susceptibility of i-SPN excitability to PD-
like dopaminergic degeneration might have implications for the un-
derstanding of the pathophysiology of PD. Findings from van den
Munckhof et al. (2003) demonstrate that early differentiation of do-
paminergic neurons is not highly dependent on the Pitx3 gene. How-
ever, survival of these neurons requires significant Pitx3 expression. It
is possible that i-SPN are less vulnerable that d-SPN to the lack of DA
Fig. 4. Spine density gradient along the dorso-ventral striatal axis in Ak mice.
(A) Representative diagram of spine density in the striatum. (B) Confocal
images along the dorso-ventral striatal axis of dendrites of SPNs in Ak mice.
Proximal (C) and distal (D) spine density of d-SPNs (top) in WT (n=20) and in
Ak mice, dorsal (n=21), middle (n=19) and ventral (n=18) and i-SPN
(bottom) in WT (n=14) and in Ak mice, dorsal (n=17), middle (n= 15) and
ventral (n= 14).
Significant differences were established by one-way ANOVA followed by
Bonferroni's test at *p < .05, **p < .01, ***p < .001 vs. WT; # p < .05, ##
p < .01, #### p < .01 vs. Ak dorsal; $p < .05 vs Ak middle.
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innervation along time. Nevertheless, Van den Munckhof et al., (2003)
made the experiments in postnatal 1 (P1), P21, P50 and P100 and more
age-dependent experiments will be necessary to understand this phe-
nomenon. As expected, we found that the excitability in i-SPNs in the
middle and ventral striatum remained unchanged. It seems likely that a
low DA concentration is sufficient to maintain the homeostatic balance
in i-SPNs.
In conclusion, we have established not only that DA modulates
striatal morphology, but that it does so through a DA concentration-
dependent manner. This highlights the importance of regional DA
concentration in the global functional striatal activity in PD patients
and in animal models. These findings may have important implications
for PD pathology and how SPN morphology evolves based on the stage
of the illness.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.nbd.2019.104666.
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Fig. 5. Changes in the excitability of d-SPN in Ak mice. (A) Firing rate of d-SPN WT mice (WT dorsal n=10 neurons, WT middle n=7 neurons and WT ventral n=7
neurons) and i-SPN WT mice (WT dorsal n= 3 neurons, WT middle n= 3 neurons and WT ventral n=4 neurons).
(B) Representative SPN spikes evoked by depolarizing current pulse (500ms) in d- and i-SPNs of WT (measured as the mean of the three WT striatal regions) and Ak
mice in the dorsal, middle and ventral striatum (Right and left panels). Note the increase of neuronal excitability of d-SPNs in the dorsal region of Ak animals. Middle
panel, Firing rate after injecting depolarizing current steps of d-SPNs (WT n=24 neurons, Ak dorsal n= 9 neurons, Ak middle n=7 neurons and Ak ventral n=8
neurons) and i-SPNs (WT n=10 neurons, Ak dorsal n=13 neurons, Ak middle n=5 neurons and Ak ventral n= 17 neurons). Two-way ANOVA followed by a
Bonferroni test showed significant differences in d-SPNs for genotype (F3,270= 7.50, P < .01) and for current values (F5,270= 50.44, P < .001). Significant dif-
ferences were established at *p < .05, **p < .01 vs. WT; # p < .05 vs. Ak dorsal, $ p < .05 vs. Ak middle. Scale bar: 50mV.
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